{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1204.16","meta":{"versionId":"10","lastUpdated":"2019-08-17T01:00:18.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"National EMS Quality Alliance Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2019-08-17"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1204.16","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1204.16"}],"version":"20190817","name":"BetaAgonist","title":"Beta Agonist","status":"active","experimental":false,"date":"2019-08-17T01:00:18-04:00","publisher":"National EMS Quality Alliance Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains beta agonist medications that are prescribed for asthma exacerbations during EMS encouners.),(Data Element Scope: The intent of this data element is to identify patients who are prescribed beta agonist therapy while being treated by EMS professionals for asthma exacerbation. Using the Quality Data Model, this particular element would map to the Medication category.),(Inclusion Criteria: Include inhalant beta agonist medications.),(Exclusion Criteria: Brand names)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1154602","display":"Albuterol Inhalant Product"},{"code":"1163444","display":"Levalbuterol Inhalant Product"},{"code":"1165719","display":"metaproterenol Inhalant Product"},{"code":"1649559","display":"Albuterol Dry Powder Inhaler"},{"code":"2108209","display":"Levalbuterol Inhalation Solution"},{"code":"2108252","display":"metaproterenol Inhalation Solution"},{"code":"214199","display":"Albuterol / Ipratropium"},{"code":"237159","display":"Levalbuterol"},{"code":"435","display":"Albuterol"},{"code":"487066","display":"levalbuterol tartrate"},{"code":"7688","display":"metaproterenol"}]}]},"expansion":{"identifier":"urn:uuid:7eba806a-9882-4fd9-8f9c-917844746da5","timestamp":"2023-12-10T23:24:53-05:00","total":11,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1154602","display":"albuterol Inhalant Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1163444","display":"levalbuterol Inhalant Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1165719","display":"metaproterenol Inhalant Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1649559","display":"albuterol Dry Powder Inhaler"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2108209","display":"levalbuterol Inhalation Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2108252","display":"metaproterenol Inhalation Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"214199","display":"albuterol / ipratropium"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"237159","display":"levalbuterol"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"435","display":"albuterol"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"487066","display":"levalbuterol tartrate"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"7688","display":"metaproterenol"}]}}